-
Controlled Balance of Self-Renewal and Differentiation in Hu
2026-05-30
This study introduces a tunable human intestinal organoid system that achieves reversible and precise control over the balance between stem cell self-renewal and differentiation. By strategically combining small molecule pathway modulators, the authors overcome prior limitations of cellular homogeneity and limited proliferative capacity, advancing the scalability and utility of organoid models for high-throughput applications.
-
Quantifying HBV Resistance: Insights from Entecavir Meta-Ana
2026-05-29
This systematic review and meta-analysis delivers the first pooled estimates of hepatitis B virus (HBV) resistance to entecavir and tenofovir over time, revealing a measurable risk for entecavir, especially in previously treated individuals. The findings underscore the urgency for robust resistance surveillance as chronic HBV therapy expands globally.
-
Distinct Roles of GluN2A/2B in Orofacial Allodynia via TG Ga
2026-05-29
This study uncovers how NMDA receptor subunits GluN2A and GluN2B distinctly regulate connexin and pannexin expression in the trigeminal ganglion during temporomandibular joint (TMJ) inflammation. These mechanistic insights clarify peripheral sensitization in orofacial pain and suggest new therapeutic avenues for temporomandibular joint osteoarthritis.
-
Dual-Action p38α Inhibitors Enhance Dephosphorylation Dynami
2026-05-28
This study demonstrates that certain p38α MAP kinase inhibitors not only block kinase activity but also accelerate phosphatase-mediated dephosphorylation of the activation loop. The findings establish a structural and mechanistic framework for improving kinase inhibitor specificity and efficacy in inflammation and cytokine signaling research.
-
Inhibiting the CaN/FoxO1/FABP4 Pathway to Prevent Atheroscle
2026-05-28
This study demonstrates that SERCA2 dysfunction accelerates atherosclerosis by activating the calcineurin/FoxO1/FABP4 pathway, which promotes foam cell formation in macrophages. Targeted inhibition of FABP4 corrects aberrant lipid metabolism, highlighting a mechanistic therapeutic avenue for atherosclerosis and metabolic disease models.
-
Microbiota and Metabolomic Shifts in Chickens with E. tenell
2026-05-27
This study investigates how ethanamizuril, sulfachlorpyridazine, and their combination modulate the cecal microbial community and metabolomic profile in chickens challenged with Eimeria tenella. The findings reveal distinct impacts of these interventions on gut microbiota stability and metabolic signatures, providing an integrated systems approach to anticoccidial efficacy assessment.
-
CPSIT_0844 Drives IL-6/IL-8 via TLR2/TLR4 in Monocyte Inflam
2026-05-27
This study uncovers how the Chlamydia psittaci protein CPSIT_0844 activates human monocytes to produce IL-6 and IL-8 through TLR2/TLR4 and downstream MAPK/NF-κB pathways. The findings illuminate a precise bacterial mechanism underlying severe inflammatory responses, advancing our understanding of psittacosis immunopathology and presenting new molecular targets for inflammatory signaling pathway research.
-
Bufalin Targets STK33 to Suppress Triple-Negative Breast Can
2026-05-26
This study identifies serine/threonine kinase 33 (STK33) as a direct molecular target of Bufalin in triple-negative breast cancer (TNBC). By elucidating the mechanism by which Bufalin induces STK33 degradation and inhibits TNBC proliferation, the research highlights a promising therapeutic axis for aggressive breast cancers lacking effective targeted options.
-
Mechanistic Insights into Diuron-Induced Acute Renal Injury
2026-05-26
This article reviews a recent study that integrates network toxicology, transcriptomics, and experimental validation to unravel the molecular mechanisms of Diuron-induced acute kidney injury. The findings highlight the JAK2/STAT1 pathway as a key mediator of nephrotoxicity, providing a foundation for future toxicological risk assessments of environmental pesticide exposure.
-
CB-5083: Applied Protocols for Selective p97 Inhibitor Workf
2026-05-25
CB-5083 empowers precise disruption of protein homeostasis and apoptosis induction in cancer and cell biology research. This guide distills advanced workflows, troubleshooting, and novel insights for maximizing p97 inhibition in both in vitro and in vivo settings, building on the latest mechanistic and translational findings.
-
Disrupting SARS-CoV-2 Nucleocapsid LLPS: GCG’s Novel Antivir
2026-05-25
The referenced study reveals that the SARS-CoV-2 nucleocapsid protein relies on RNA-triggered liquid–liquid phase separation (LLPS) for viral replication. Targeting this process, (-)-gallocatechin gallate (GCG) effectively inhibits both LLPS and viral propagation, opening a new avenue for antiviral research and chemical probe development.
-
Mitochondrial NAD+ Deficiency Drives Aortic Aneurysm via Col
2026-05-24
This study uncovers mitochondrial NAD+ deficiency in vascular smooth muscle as a previously unrecognized cause of thoracic and abdominal aortic aneurysm. Through multiomics and genetic models, the authors link impaired mitochondrial NAD+ homeostasis to defective collagen III turnover, offering new mechanistic insight and highlighting potential molecular targets in aortic disease.
-
PA-Src-FAK-RhoA/ROCK Pathway Drives Decidual Cytoskeletal Ch
2026-05-23
This study illuminates the critical role of the phosphatidic acid (PA)-Src-FAK-RhoA/ROCK pathway in orchestrating cytoskeletal rearrangements during decidualization of human endometrial stromal cells. These findings refine our understanding of endometrial remodeling and suggest new molecular targets for investigating implantation-related infertility.
-
Cytoskeleton-Dependent Mechanotransduction in Autophagy Indu
2026-05-22
This study establishes that mechanical stress-induced autophagy in human cells is critically dependent on the cytoskeleton, particularly on microfilaments. By pharmacologically modulating cytoskeletal components, the authors provide mechanistic clarity on how cells convert mechanical cues into autophagic responses, offering a foundation for future research into mechanotransduction and calcium signaling pathways.
-
CD44-Driven Metabolic Rewiring in IDH-Mutant AML: Therapeuti
2026-05-22
The reference study identifies CD44-mediated metabolic rewiring as a critical dependency in IDH-mutant acute myeloid leukemia (AML), enabling sustained NADPH generation for elevated (R)-2-hydroxyglutarate production. Targeting this axis, especially in combination with IDH2 inhibition, unveils new avenues for overcoming resistance in hematologic malignancies with IDH mutations.